Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Thu, 05/10/18 - 10:17 am
Tags:
Eli Lilly, ARMO BioSciences, M&A
Eli Lilly Shares Seen Rising 18% as Profits Surge
Investopedia
Fri, 05/4/18 - 11:47 am
Tags:
Eli Lilly
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Biopharma Dive
Thu, 05/3/18 - 12:11 pm
Tags:
Eli Lilly, Sanofi, Pfizer, patents, patent lawsuits, FDA
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
Reuters
Tue, 04/24/18 - 10:47 pm
Tags:
Express Scripts, migraines, PBMs, Amgen, Eli Lilly
Lilly’s strong Q1 cushions the blow of FDA thumbs-down on high-dose baricitinib
Fierce Pharma
Tue, 04/24/18 - 10:44 pm
Tags:
Eli Lilly, earnings, baricitinib
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Mon, 04/23/18 - 11:15 pm
Tags:
Eli Lilly, FDA, advisory panels, rheumatoid arthritis, baricitinib, Incyte
Big Week Ahead for Eli Lilly: Here's What to Look For
Motley Fool
Sun, 04/22/18 - 12:12 pm
Tags:
Eli Lilly, earnings, FDA, Incyte, olumiant, rheumatoid arthritis
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms
Xconomy
Fri, 04/20/18 - 09:30 am
Tags:
Eli Lilly, baricitinib, olumiant, rheumatoid arthritis
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Tags:
Pfizer, M&A, Bristol-Myers Squibb, Celgene, Eli Lilly, AstraZeneca
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Thu, 04/5/18 - 08:59 am
Tags:
Eli Lilly, Janssen, Merck, drug pricing, drug discounts
Pharma turns to new pain options amid opioid crisis
Biopharma Dive
Thu, 04/5/18 - 08:58 am
Tags:
opioids, opioid crisis, painkillers, payers, Eli Lilly, abuse deterrents
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Wed, 04/4/18 - 09:08 am
Tags:
Eli Lilly, Sigilon, cell therapies, drug development, type 1 diabetes
Lilly's Cyramza succeeds in late-stage liver cancer trial
Yahoo/Reuters
Wed, 04/4/18 - 08:55 am
Tags:
Eli Lilly, Cyramza, liver cancer, clinical trials
Tired of finishing in last place, Eli Lilly’s new R&D chief wants to shake things up
Endpoints
Mon, 04/2/18 - 12:12 pm
Tags:
Eli Lilly, R&D, Dan Skovronsky
Half-off sale at Eli Lilly as drug rebating climbs to 51% in 2017
Fierce Pharma
Sat, 03/31/18 - 09:56 am
Tags:
Eli Lilly, drug rebates, drug pricing, diabetes
Investors in AbbVie, Lilly, Amgen and more set to vote on executive pay, drug pricing
Fierce Pharma
Tue, 03/27/18 - 10:00 pm
Tags:
AbbVie, Eli Lilly, Amgen, executive pay, drug pricing
Lilly's bet on pain stands out amid bare pharma pipeline
Biopharma Dive
Mon, 03/26/18 - 09:58 pm
Tags:
Eli Lilly, painkillers, galcanezumab, tanezumab, Lasmiditan
CVS to Hire Former Eli Lilly CFO to Run Pharmacy Benefit Business
Morningstar
Tue, 03/20/18 - 03:31 pm
Tags:
CVS, Eli Lilly, PBMs
In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle
Endpoints
Fri, 03/9/18 - 10:48 am
Tags:
Eli Lilly, Merck KGaA, Btk inhibitors, autoimmune disease, evobrutinib
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Wed, 03/7/18 - 12:00 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, heart failure, exercise, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.